Tagged: cfo
26 results
Simon Biddiscombe
Simon Biddiscombe is a British-born technology executive and chartered accountant who has spent more than two decades in senior finance and leadership roles across Silicon Valley. He is Executive Vice Chairman and a board member of MicroVision, the Redmond-based laser beam scanning and lidar company, a role he took in September 2025. He is best known for leading enterprise security firm MobileIron as CEO through its 2020 sale to Ivanti, and earlier for rising from CFO to CEO at semiconductor networking company QLogic. His career began at PricewaterhouseCoopers and includes CFO stints at Mindspeed Technologies and Wyle Electronics, plus an Executive Partner role at private equity firm Thomas H. Lee Partners.
Tom Soloway
Tom Soloway is the Chief Executive Officer of T-knife Therapeutics, a transatlantic biotech developing T-cell receptor (TCR-T) therapies aimed at solid tumors. With more than 25 years across strategy, operations, corporate finance and venture capital, he has helped build and finance a string of life sciences companies including Transcept Pharmaceuticals, Ascendis Pharma and Audentes Therapeutics. He took the helm of T-knife in January 2021, positioning the Berlin- and San Francisco-based company to move its 'supercharged' TCR-T candidates into the clinic while staying lean and capital-efficient.
Yogi Goel
Yogi Goel is the co-founder and CEO of Maxima, an agentic AI platform that automates the month-end accounting close for enterprises. He spent two decades in the office of the CFO - auditing at EY, running M&A and IPOs at Citi and Barclays, and seven years at Rubrik as a strategic finance leader, where he helped scale the company from $5M to $900M in ARR through its 2024 NYSE IPO. In 2024 he founded Maxima with Akshaya Srivatsa and Jack Liao, raising $41M from Redpoint Ventures, Kleiner Perkins, and Audacious Ventures to rebuild accounting operations around AI agents that reconcile, post journal entries, and co-prepare financial reports alongside human teams.
Chris McNulty
Chris McNulty is the interim CEO of Ring Therapeutics, a Cambridge, Massachusetts biotech developing genetic medicines that use commensal anelloviruses as delivery vectors. An MIT-trained engineer with a Harvard MBA, he joined Ring in May 2023 as Chief Financial Officer and Head of Corporate Strategy and stepped up to lead the company in December 2024. Over more than 15 years in pharma and biotech finance, he has closed financing transactions worth more than $300 million across companies including VBI Vaccines, InVivo Therapeutics, Repligen, and Genzyme.
Daniel Gennaoui
Daniel (Dan) Gennaoui is an education operator who serves as Chief of Staff to the Co-CEO of Uncommon Schools, a nonprofit network of urban charter schools serving roughly 20,000 students across New York, New Jersey, and Massachusetts. A former Teach For America corps member turned classroom teacher, he has spent two decades building the operational and financial backbone of high-performing charter networks - including a stint as Chief Operating Officer and later Chief Financial Officer at KIPP Nashville, where he helped grow enrollment from about 1,100 to more than 3,000 students. He holds a BS from Cornell, an MA from Bank Street College of Education, and an MBA from Columbia Business School.
Daniel Suchi
Daniel Suchi is a New York-based operating executive at Grips Intelligence, an e-commerce market intelligence platform that tracks online sales across marketplaces and brands. He leads operations and finance, having previously built and scaled businesses at Akooda and Yotpo. With an MBA from MIT Sloan and time at Harvard Kennedy School, Suchi works at the intersection of data, revenue operations, and go-to-market strategy, helping retailers, manufacturers, and investors turn digital sales signals into growth decisions.
Elizabeth Czerepak
Elizabeth Czerepak is a life sciences finance executive with more than three decades in big pharma, venture capital, and public biotech. She is Chief Financial Officer and VP of Corporate Development at Mirror Biologics, a clinical-stage immunotherapy company in Wesley Chapel, Florida, where she also served as acting CEO from July 2024 to May 2025. Over her career she has helped raise hundreds of millions of dollars, taken companies public through IPOs and SPAC mergers, and worked on landmark pharma transactions including the search that led to BASF Pharma's sale to Abbott. She sits on the boards of Delcath Systems and TransCode Therapeutics.
Patti Soch
Patti Soch is the Chief Executive Officer of Liquibase, an Austin-based database DevOps company that started life as Datical. She joined in 2016 as CFO after finance leadership roles at Gazzang (acquired by Cloudera), Phurnace Software (acquired by BMC), and Tango Health, and stepped into the CEO seat in 2022. She is known for an inclusive, transparent leadership style and for pushing Liquibase's open-source database change management platform into enterprise and public-sector accounts.
Rich Small
Rich Small is the CEO of Neurotech Pharmaceuticals, the Cumberland, Rhode Island clinical-stage biotech that in March 2025 won FDA approval for ENCELTO, the first and only treatment for macular telangiectasia type 2 (MacTel). A CPA and Northeastern University graduate, he joined Neurotech as CFO in 2007 and took over the top job in 2016, guiding the company's encapsulated cell technology platform from experimental science to a commercial retinal implant.
Milo Krastev
Milo Krastev is the co-founder of Foodsmart (formerly Zipongo), the San Francisco company that turned nutrition into a covered health benefit for more than three million Americans. He spent a decade as the company's CFO and Head of Growth before handing off the finance chair in 2025 to run strategy and business development full time. Before Foodsmart he moved through the rooms where big money gets allocated - investment banking at Bank of America Merrill Lynch, activist investing at ValueAct Capital, and financial strategy at Palantir - then bet the whole resume on the idea that food, not just pills, belongs on a prescription pad.
Peyton Marshall
Peyton Marshall is the founder, Chairman, and CEO of LeveragePoint, a Newton, Massachusetts SaaS company that helps B2B firms quantify, communicate, and capture the economic value of what they sell. An economist by training with a PhD from MIT, he spent twelve years in investment banking in London at UBS and Goldman Sachs, then fifteen years as a CFO and operator in healthcare and IT companies, before founding LeveragePoint in 2009 to turn value-based pricing from a theory into an everyday sales tool. He has grown the company to multi-million-dollar revenue without raising venture capital.
Dave Licata
Dave Licata is a Stanford-trained mechanical engineer turned biotech operator who co-founded TORL BioTherapeutics with legendary UCLA oncologist Dennis Slamon. As President and CFO (and founding CEO), he built TORL into a clinical-stage oncology company developing antibody-drug conjugates against targets like Claudin 6 and Claudin 18.2, raising more than $450 million while keeping a reputation for capital efficiency. He is also Executive Chairman of 1200 Pharma and previously founded Holoclara and served as an Entrepreneur in Residence at Caltech.
Kenneth Lee
Kenneth Lee is the Chief Financial Officer and Treasurer, and Executive Vice President of Finance and Administration, at Southern New Hampshire University, one of the largest nonprofit providers of online higher education in the United States. Since 2018 he has steered the money behind a 16,000-employee institution that turned a small regional college into a national online powerhouse, overseeing finance, accounting, financial planning, treasury, tax, internal controls, procurement, and the campus and facilities themselves. A two-time Harvard graduate and former A.T. Kearney partner, Lee spent seventeen years in consulting and senior corporate roles before deciding the most interesting balance sheets were the ones attached to a mission.
Lawrence Herman
Lawrence Herman is the Chief Financial Officer and AI Strategy Leader at Cents, the all-in-one operating system for laundromats and dry cleaners. A payments and fintech finance veteran, he has steered the books at Dwolla, Accrete, and Paxful, and logged earlier stretches at Mastercard, American Express, Dataminr, EY, Citi, Morgan Stanley, and Goldman Sachs. Harvard-trained in economics, he is known for calm during industry cycles, a preacher's zeal for financial literacy, and a habit of walking into every meeting with three discussion points and three asks.
Nihad Rahman
Nihad Rahman is the CEO of ezCater, the Boston-founded online marketplace that turns office lunch into logistics across 100,000+ restaurants. He joined in 2022 as CFO after two decades in finance at JPMorgan Chase and General Electric, stepped in as interim chief in January 2025, and was handed the permanent job that May - succeeding 16-year co-founder Stefania Mallett. He runs a roughly 850-person company from Bronxville, New York, commuting to the downtown Boston headquarters rather than the other way around.
Jim Collins
Jim Collins is the Chief Executive Officer of Basic American Foods, a 90-plus-year-old, family-owned food manufacturer headquartered in Walnut Creek, California. He stepped into the CEO seat in 2023 after serving as the company's CFO. Before BAF, his career wound through PwC, Foster's Group in Australia, Robert Mondavi, Beringer, and a stint at telecom-era start-ups Yipes and Spinway. A Chico State business graduate, he runs a roughly $625M revenue, 1,300-employee enterprise best known for instant mashed potatoes, dehydrated onion and garlic, beans and foodservice ingredients sold under brands like Idaho Spuds, Potato Pearls, Santiago, and Golden Grill.
Frank Calderoni
Frank Calderoni is a tech-industry lifer who spent a decade as Cisco's CFO, then jumped into the CEO seat at Anaplan in 2017, taking the connected-planning company through its 2018 IPO and a $10.7B sale to Thoma Bravo in 2022. He briefly ran Velocity Global, sits on Adobe's board as Lead Director, and wrote 'Upstanding,' a book arguing that company character is a competitive moat.
Paul McKnight
Paul McKnight runs the North American arm of John Paul, the Paris-born concierge group that quietly answers the phone when private-jet calendars implode and Michelin reservations vanish. A career CFO turned chief executive, he is the operations spine behind a 600-concierge global network serving luxury brands and their highest-spending customers.
Thomas Moran
Thomas (Tom) Moran is the former President and CEO of Goodwill Central Coast, the Salinas-based nonprofit that runs retail thrift stores, donation centers, and job-training programs across Santa Cruz, Monterey, and San Luis Obispo counties. A physics major turned MBA turned retail-finance lifer, he came in as CFO in 2018 and was elevated to CEO in 2020 after stints at Conn's, West Marine, ARAMARK, Limited Brands, and CarMax.
Alex Kamenetskiy
Alex Kamenetskiy is Managing Director, COO and CFO of Munich Re Ventures, the venture arm of one of the world's largest reinsurers. He helped scale the firm from a $50 million off-balance-sheet experiment into a $1B+ multi-fund platform, building the back office, the team, and the playbook that lets MRV write checks alongside Lightspeed and the rest of Sand Hill Road. He invests across cybersecurity, climatetech, healthtech, insurtech, and the future of transportation.
Casey Woo
Casey Woo is the founder and General Partner of FOG Ventures and founder/CEO of Operators Guild, the invite-only community of more than 1,000 strategic finance and operations leaders. A seven-time high-growth CFO/COO whose resume runs through Morgan Stanley, Maverick Capital, Pantheon, Zozi, WeWork and Landing, he now backs founders building the modern operator toolbox alongside a syndicate of the world's top CEOs, COOs and CFOs.
Steve Reale
Steve Reale is General Partner & CFO at Ulu Ventures, a Palo Alto-based seed-stage venture firm with $400M+ AUM known for backing diverse founders using a rigorous, data-driven decision analysis framework. A Kauffman Fellow (Class 14) with a CFA designation and 25+ years of Silicon Valley experience spanning equity research, early-stage startups, and venture investing, Reale brings an unusually analytical lens to seed-stage bets - applying probability-weighted risk modeling borrowed from pharmaceutical R&D and oil & gas exploration to evaluate founders and markets. His portfolio work spans 10 unicorns including Guild Education, BetterUp, and Figure.
John Glasgow
John Glasgow is the founder, CEO, and CFO of Campfire, the AI-native ERP platform built for high-growth tech companies. A 15-year finance veteran who passed through Adobe, Invoice2go, and Bill.com before founding Campfire during parental leave in 2023, Glasgow has raised over $100 million in funding — $35M Series A and $65M Series B in just 12 weeks — and is steering the company toward an IPO. His platform's proprietary Large Accounting Model (LAM) achieves 95% accuracy on financial workflows, and customers like Replit, Decagon, and PostHog have traded NetSuite for Campfire's AI-first stack.
Pat Cotroneo
Pat Cotroneo is a seasoned life sciences financial executive who spent over two decades at FibroGen, Inc. (now Kyntra Bio), serving as Chief Financial Officer from 2008 to 2021. During his tenure, he guided FibroGen through two defining transformations: its landmark 2014 IPO - the largest biotech public offering in 12 years - and its evolution into a commercial-stage company with the launch of roxadustat in China in 2019. With 25+ years of senior financial leadership in life sciences, Cotroneo built his career at Deloitte & Touche, SyStemix (a Novartis subsidiary), and ultimately FibroGen, where he oversaw finance, accounting, human resources, and information technology before transitioning to Executive Advisor to the CEO.
Brian Roberts
Brian Roberts is a General Partner at Andreessen Horowitz (a16z), where he works across the American Dynamism and AI Apps funds. Known as BK to those in the know, Roberts is a serial CFO turned investor who took Lyft public at a $24 billion valuation, helped Splunk get acquired by Cisco for $28 billion, and was OpenSea's first CFO during the NFT boom. With 30+ years spanning investment banking at Evercore, corporate development at Microsoft and Walmart, and C-suite finance roles at some of tech's most pivotal companies, he joined a16z in October 2024 to bring an operator's lens to early and growth-stage investments in enterprise software, fintech, and America's strategic tech infrastructure.
James Chan
James Chan is the CFO of LDV Capital, a New York-based early-stage venture fund investing in visual technology and AI startups. With 20+ years spanning public accounting, Fortune 500 corporate finance, and CFO roles at hypergrowth startups and venture firms, he founded JMC Strategic Advisory in 2022 to serve as a fractional CFO across multiple funds simultaneously - including Bow Capital, BankTech Ventures, Breakout Ventures, Lineate, and First Spark Ventures - overseeing more than $1 billion in assets under management. He holds a BA from UCLA and an MS in Business Taxation from USC, and is known for eating ice cream with chopsticks.